RecallDepth
Class II Completed

ROPivacaine HCl 0.2% PF in Sodium Chloride 1,000 mg/500 mL (2 mg per mL) Injection, 500 mL bags, Rx only, STAQ Pharma Inc. 14135 E 42nd Ave, Unit 50, Denver, Colorado 80239, NDC 73177-0109-26,

Company
Staq Pharma, Inc.
Recall Initiated
November 29, 2023
Posted
December 13, 2023
Recall Number
D-0147-2024
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
2616 bags
Firm Location
Denver, CO, United States

Reason for Recall

STAQ Pharma Inc. received consumer complaints related to leaking bags and other potential bag concerns. Upon investigation, they determine the source of the issue was with the bag manufacturer who released bags Lot # 134142-001A which had failed internal QC tests for leaks.

Distribution

Nationwide within the United States

Lot / Code Info

Lot#: 23109472A, Exp. date 03/10/2024; 23109473A, Exp. date 03/11/2024; 23109474A, Exp. date 03/13/2024; 23109491A, Exp. date 03/16/2024; 23109492A, Exp. date 03/19/2024; 23109501A, Exp. date 03/25/2024; 23109520A, Exp. date 04/10/2024; 23109521A, Exp. date 04/13/2024; 23109522A, Exp. date 04/03/2024.

More recalls by Staq Pharma, Inc.

View all recalls by this company →

Other recent Class II Drug recalls